Patient-reported experiences of pulmonary fibrosis in the UK: The role of sex and disease subtypes in symptomology, diagnosis and care
Therapeutic Advances in Respiratory Disease · 2026
DOI: 10.1177/17534666261492562 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2026. Verfasst von Georgie May Massen und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Imperial College London, London, England. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Healthcare Disparities, Alveolitis, Extrinsic Allergic. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pulmonary fibrosis (PF) is associated with substantial symptom burden, complex diagnostic pathways and varied access to specialist services. It is important to understand patient and carer experiences to highlight disparities and inform improvements in care.
Objectives
To explore reported insights from patients and carers regarding PF symptomology, initial healthcare experiences, access to support services, and whether experiences differ by sex and PF subtype.
Design
A cross-sectional analysis of the 2025 PF State of the Nation Survey, conducted by Action for Pulmonary Fibrosis.
Methods
Using the survey results which included information from 1,270 individuals (73.78% patients) with lived experience of PF. Differences in symptoms, diagnostic pathways and patient experience were examined using Chi-squared and Fishers exact tests.
Results
Respondents with idiopathic pulmonary fibrosis (IPF) were more likely to be male, whilst female dominance was observed in those reporting diagnosis of non-IPF-PF. Males were diagnosed at an older age than females, were referred to respiratory services more quickly, and had fewer primary care appointments prior to referral. More than 90% of the cohort reported symptoms prior to diagnosis, but symptomology differed by PF subtype; breathlessness was more commonly reported by those with hypersensitivity pneumonitis (p=0.004) and cough was more commonly reported by people with sarcoidosis (p=0.025). Almost one quarter (24.93%) of people reported symptoms to a physician only after experiencing them for at least one year. Treatment burden was high, antifibrotic side effects were common and differences with respect to age and sex were observed.
Conclusions
Important differences in symptom burden, diagnostic experiences and access to support exist across PF subtypes and between sexes. These findings highlight potential weaknesses in current diagnostic pathways, as well as unmet needs related to referral delays, treatment side effects and support services. Enhancing patient-centred care and targeted service provision may help to reduce inequalities and improve outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Public Health, Imperial College London, London, England.
- The George Institute, Imperial College London, London, England.
- Action for Pulmonary Fibrosis, Peterborough, England.
- School of Medicine, Department of Life and Health Sciences, Ulster University, Londonderry, Northern Ireland, UK.
- Altnagelvin Area Hospital, Western Health and Social Care Trust, Londonderry, Northern Ireland, UK.
ORCID-Profile: Georgie May Massen
Zitieren
APA
Massen, G. M., Murray, L., Chaudhuri, N., & Price, B. (2026). Patient-reported experiences of pulmonary fibrosis in the UK: The role of sex and disease subtypes in symptomology, diagnosis and care. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666261492562
Vancouver
Massen GM, Murray L, Chaudhuri N, Price B. Patient-reported experiences of pulmonary fibrosis in the UK: The role of sex and disease subtypes in symptomology, diagnosis and care. Therapeutic Advances in Respiratory Disease. 2026. doi:10.1177/17534666261492562
BibTeX
@article{Massen2026,
author = {Massen, Georgie May and Murray, Lisa and Chaudhuri, Nazia and Price, Bradley},
title = {Patient-reported experiences of pulmonary fibrosis in the UK: The role of sex and disease subtypes in symptomology, diagnosis and care},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2026},
doi = {10.1177/17534666261492562}
}
EUVIMED